世界最新医学信息文摘（电子版）
世界最新醫學信息文摘（電子版）
세계최신의학신식문적（전자판）
World Latest Medicine Information
2013年
10期
12-13
,共2页
急性脑梗死%舒血宁%临床疗效%神经功能
急性腦梗死%舒血寧%臨床療效%神經功能
급성뇌경사%서혈저%림상료효%신경공능
Acute cerebral infarction%Shuxuening%The clinical curative effect%Nerve function
目的探讨舒血宁治疗急性脑梗死(AIS)的临床疗效及其对神经功能恢复的影响。方法对我院收治的160例 AIS患者随机分为治疗组和对照组。对照组80例，给予基础治疗，治疗组80例，在基础治上再给予舒血宁注射治疗，治疗15天后对两组临床疗效及患者的神经功能的恢复情况予以比较，进行评价分析。结果临床总体治疗效果：治疗组总有效率为86.25%，对照组(62.50%)，差异显著有统计学意义。神经功能恢复情况：治疗前两组 NIHSS (National Institute of Health stroke scale，美国国立卫生院神经功能缺损评分)比较，差异无统计学意义(P >0.05)，治疗15天后，治疗组 NIHSS 评分显著下降，与对照组比较差异均有统计学意义P <0.05)；治疗过程中，两组均无明显不良反应。结论舒血宁治疗急性脑梗死（AIS），能显著提高临床疗效，降低患者的神经功能损伤，安全性高，能有效提高患者的生活质量，在临床应用中值得推广。
目的探討舒血寧治療急性腦梗死(AIS)的臨床療效及其對神經功能恢複的影響。方法對我院收治的160例 AIS患者隨機分為治療組和對照組。對照組80例，給予基礎治療，治療組80例，在基礎治上再給予舒血寧註射治療，治療15天後對兩組臨床療效及患者的神經功能的恢複情況予以比較，進行評價分析。結果臨床總體治療效果：治療組總有效率為86.25%，對照組(62.50%)，差異顯著有統計學意義。神經功能恢複情況：治療前兩組 NIHSS (National Institute of Health stroke scale，美國國立衛生院神經功能缺損評分)比較，差異無統計學意義(P >0.05)，治療15天後，治療組 NIHSS 評分顯著下降，與對照組比較差異均有統計學意義P <0.05)；治療過程中，兩組均無明顯不良反應。結論舒血寧治療急性腦梗死（AIS），能顯著提高臨床療效，降低患者的神經功能損傷，安全性高，能有效提高患者的生活質量，在臨床應用中值得推廣。
목적탐토서혈저치료급성뇌경사(AIS)적림상료효급기대신경공능회복적영향。방법대아원수치적160례 AIS환자수궤분위치료조화대조조。대조조80례，급여기출치료，치료조80례，재기출치상재급여서혈저주사치료，치료15천후대량조림상료효급환자적신경공능적회복정황여이비교，진행평개분석。결과림상총체치료효과：치료조총유효솔위86.25%，대조조(62.50%)，차이현저유통계학의의。신경공능회복정황：치료전량조 NIHSS (National Institute of Health stroke scale，미국국립위생원신경공능결손평분)비교，차이무통계학의의(P >0.05)，치료15천후，치료조 NIHSS 평분현저하강，여대조조비교차이균유통계학의의P <0.05)；치료과정중，량조균무명현불량반응。결론서혈저치료급성뇌경사（AIS），능현저제고림상료효，강저환자적신경공능손상，안전성고，능유효제고환자적생활질량，재림상응용중치득추엄。
Objective To investigate the treatment of acute cerebral infarction (AIS) effects on the clinical efficacy and nerve function recovery. Method The hospital treated 160 cases of AIS patients were randomlydivided into treatment group and control group. A control group of 80cases, given the basic treatment, the treatment group of 80 cases, and then given Shuxuening Injection in the treatment of the foundation treatment, compared to recovery after 14 days of therapy of two groups of clinical curative effect and the neurological function, evaluation and analysis. Results The clinical overall therapeutic effect: the total effective rate of treatment group was 86.25%, control group (62.50%), significant difference has statistics significance. The recovery of neurological function: Before treatment in two groups (NIHSS National Institute of Health Stroke Scale score, the United States of America NIH neural function defect), no significant difference (P > 0.05), 15 days after treatment, NIHSS score of the treatment group decreased significantly compared with the control group, the differences were statistically significant at P< 0.05); In the course of treatment, two groups had no significant adverse reactions. Conclusion The treatment of acute cerebral infarction (AIS), Shuxuening injection can significantly improve the clinical efficacy, reduce neurological injury, high safety, can effectively improve the quality of life of patients, is worthy to be popularized in clinical application.
